MBX Biosciences
MBX
MBX Biosciences (MBX) earnings history
Most recent quarter
- Fiscal period
- Q4 2024
- Period end
- Dec 31, 2024
- EPS actual
- −$0.47
- EPS estimate
- −$0.57
- EPS surprise
- +17.99%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Mar 17, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2024 | Mar 17, 2025 | −$0.57 | −$0.47 | +17.99% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did MBX Biosciences (MBX) last report earnings?
MBX Biosciences last reported on Mar 17, 2025, covering fiscal Q4 2024.
Did MBX beat earnings estimates?
Yes. MBX Biosciences reported EPS of −$0.47 for Q4 2024 against a −$0.57 estimate — a 17.99% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.